Ehlers-Danlos Syndrome Clinical Trial
Official title:
Disordered Bleeding in Ehlers Danlos Syndromes
Ehlers-Danlos Syndrome (EDS) is a disease that weakens the connective tissues (i.e. tendons and ligaments) in the human body. EDS can make the joints loose and alter skin and wound healing. It can also weaken blood vessels and organs. Many EDS patients are referred for investigation of bleeding symptoms. Although most patients will have mild symptoms such as bruising, many will experience significant bleeding that can be life-threatening. The physiological reason behind this has not been identified and therefore, treating this is challenging. In addition, patients with EDS frequently require major surgery due to complications from their connective tissue disease. These surgery carries a significant risk of catastrophic bleeding which is further magnified in this group of patients. The specific reason of clinical bleeding in patients with EDS is likely multifactorial, including skin and blood vessel fragility leading to increased bruising and poor wound healing, coagulopathies related to factor deficiency, acquired vonWillebrand disease (VWD), and notable platelet dysfunction. Despite compelling preliminary evidence, there is limited data on the diagnosis and management of platelet dysfunction in EDS patients. Therefore, in this study we will characterize hemostasis, the medical term which refers to the process of stopping blood flow, across the three most common subtypes of EDS.we will also determine the burden of illness of pathologic bleeding in patients with Ehlers-Danlos Syndrome (EDS) using validated patient reported tools.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04437589 -
Opioid-Free Anesthesia for Patients With Joint Hypermobility Syndrome Undergoing Craneo-Cervical Fixation: A Case-series
|
||
Completed |
NCT04680793 -
Effects of a Multidisciplinary Outpatient Rehabilitation Program in Patients With Ehlers-Danlos Syndrome.
|
N/A | |
Not yet recruiting |
NCT05279937 -
The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients
|
Phase 3 | |
Enrolling by invitation |
NCT05429996 -
Ultrastructural Collagen Markers in Ehlers Danlos Syndromes
|
||
Not yet recruiting |
NCT03575182 -
Gait Retraining in Patients With Joint Hypermobility Syndrome/Hypermobile Ehlers Danlos Syndrome
|
N/A | |
Recruiting |
NCT05561270 -
Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome
|
N/A | |
Completed |
NCT01322165 -
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
|
N/A | |
Active, not recruiting |
NCT05603741 -
Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers
|
Phase 4 | |
Completed |
NCT01356134 -
Vascular Fundus Changes in Patients With High Probability of Chronic Cerebrospinal Venous Insufficiency (CCSVI)
|
N/A | |
Completed |
NCT05137379 -
Evaluation of a Cohort of Patients With Ehlers-Danlos Syndrome Treated With Orthopedic Surgery (SED-eval)
|
||
Recruiting |
NCT02050113 -
Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices
|
N/A | |
Recruiting |
NCT04890431 -
Impact of Oxygen Therapy on Fatigue in Patients With Hypermobile-type Ehlers-Danlos Syndrome
|
Phase 4 | |
Completed |
NCT03602482 -
Standing Cognition and Co-morbidities of POTS Evaluation
|
N/A | |
Recruiting |
NCT04133272 -
Registry of Ehlers-Danlos Syndrome
|
||
Completed |
NCT05516043 -
Safety and Performance of POLYTHESE® Vascular Prosthesis
|
||
Recruiting |
NCT06105541 -
Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation
|
N/A | |
Enrolling by invitation |
NCT04036305 -
Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers
|
||
Recruiting |
NCT03596437 -
Study of Arterial Properties by Ultra-high Frequency Ultrasound in Fibromuscular Dysplasia and Vascular Ehlers-Danlos Syndrome
|
N/A | |
Completed |
NCT00270686 -
Studies of Heritable Disorders of Connective Tissue
|
||
Completed |
NCT00001966 -
Mind-Body Therapy for Pain in Ehlers-Danlos Syndrome
|
Phase 2 |